CapForce Inc.
CFOR - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$120.69M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $120.69 Million |
|---|---|
| Enterprise Value | $122.30 Million |
| Earnings per Share | $2.33 |
| Beta | 0 |
| Outstanding Shares | 12,378,671 |
Return
| Return on Equity | 83.85% |
|---|---|
| Return on Assets | 71.03% |
| Return on Invested Capital | 85.75% |
Valuation & Multiples
| P/E Ratio | 1.82 |
|---|---|
| PEG | 0.16 |
| Price to Sales | 1.63 |
| Price to Book Ratio | 1.63 |
| Enterprise Value to Revenue | 1.6 |
| Enterprise Value to EBIT | 1.88 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-48.00
Consensus analyst estimateRevenue Estimate
$1.33 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-48.00
Consensus analyst estimateRevenue Estimate
$1.33 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Opgen Inc
3 employees
CEO: Oliver Schacht
CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States an...